УДК 616-07
K. ERSHOVA¹, BRIAN M. LUNA³, JUN YAN³, V. ZELMAN^1,2, HOLLY MUIR², I. SAVIN⁵, J. SAVOCHKINA⁶, S. DUBILEY^1,4, B. SPELLBERG^3
1Skolkovo Institute of Science and Technology, Moscow c., Russia,
²Department of Anesthesiology, Keck School of Medicine at University of Southern California, Los Angeles c., California, USA,
³Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles c., CA, USA,
⁴Scientific Research Neurosurgery Institute named after the academician Nikolay Burdenko,
⁵Institute of Gene Biology of the Russian Academy of Sciences, Moscow c., Russia,
⁶Federal Budget Institution of Science "Central Research Institute of Epidemiology" of The Federal Service on Customers' Rights Protection and Human Well-being Surveillance, Moscow c., Russia
NOSOCOMIAL PATHOGENS AND ANTIBIOTIC RESISTANCE

Nosocomial infections caused by antibiotic resistant bacteria are challenging for healthcare professionals and for our entire society. Clinicians and pa-tients in intensive care units (ICU)s experience the greatest burden from nosocomial infections mostly because of the broad use of invasive devices, and therefore new approaches in treatment as well as in diagnostics are urgently needed for ICU infections. This article discusses some advances in the diagnostics and treatment of healthcare-associated infections in ICU. One is related to diagnostics of nosocomial meningitis. We found the presence of bacteria, in select cases of post-neurosurgical aseptic meningitis. Another ongoing research project reveals the benefits of transferrin in the treatment of nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae in vitro.

скачать